CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
7.53
+0.54 (7.73%)
At close: Dec 10, 2025, 4:00 PM EST
7.75
+0.22 (2.92%)
After-hours: Dec 10, 2025, 7:40 PM EST
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $4.67 million as of December 10, 2025. Its market cap has decreased by -37.50% in one year.
Market Cap
4.67M
Enterprise Value
-5.16M
1-Year Change
-37.50%
Ranking
Category
Stock Price
$7.53
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $4.67M, a decrease of -93.32%. That is a compound annual growth rate of -35.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 4.34M | -37.33% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | 40.05M | -37.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |